164 related articles for article (PubMed ID: 29968184)
1. Model-Based Residual Post-Processing for Residual Model Identification.
Ibrahim MMA; Nordgren R; Kjellsson MC; Karlsson MO
AAPS J; 2018 Jul; 20(5):81. PubMed ID: 29968184
[TBL] [Abstract][Full Text] [Related]
2. Model-Based Conditional Weighted Residuals Analysis for Structural Model Assessment.
Ibrahim MMA; Ueckert S; Freiberga S; Kjellsson MC; Karlsson MO
AAPS J; 2019 Feb; 21(3):34. PubMed ID: 30815754
[TBL] [Abstract][Full Text] [Related]
3. Variability Attribution for Automated Model Building.
Ibrahim MMA; Nordgren R; Kjellsson MC; Karlsson MO
AAPS J; 2019 Mar; 21(3):37. PubMed ID: 30850918
[TBL] [Abstract][Full Text] [Related]
4. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
Hooker AC; Staatz CE; Karlsson MO
Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
[TBL] [Abstract][Full Text] [Related]
5. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling.
Jaber MM; Brundage RC
J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):123-132. PubMed ID: 36617366
[TBL] [Abstract][Full Text] [Related]
6. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
[TBL] [Abstract][Full Text] [Related]
7. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comets E; Brendel K; Mentré F
Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
[TBL] [Abstract][Full Text] [Related]
8. A strategy for residual error modeling incorporating scedasticity of variance and distribution shape.
Dosne AG; Bergstrand M; Karlsson MO
J Pharmacokinet Pharmacodyn; 2016 Apr; 43(2):137-51. PubMed ID: 26679003
[TBL] [Abstract][Full Text] [Related]
9. Assessment of type I error rates for the statistical sub-model in NONMEM.
Wählby U; Bouw MR; Jonsson EN; Karlsson MO
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
[TBL] [Abstract][Full Text] [Related]
10. Development and performance of npde for the evaluation of time-to-event models.
Cerou M; Lavielle M; Brendel K; Chenel M; Comets E
Pharm Res; 2018 Jan; 35(2):30. PubMed ID: 29368033
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework.
Centanni M; Reijnhout N; Thijs A; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Jun; 63(6):871-884. PubMed ID: 38842789
[TBL] [Abstract][Full Text] [Related]
12. Use of a linearization approximation facilitating stochastic model building.
Svensson EM; Karlsson MO
J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):153-8. PubMed ID: 24623084
[TBL] [Abstract][Full Text] [Related]
13. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
[TBL] [Abstract][Full Text] [Related]
14. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy.
Maharaj AR; Wu H; Hornik CP; Arrieta A; James L; Bhatt-Mehta V; Bradley J; Muller WJ; Al-Uzri A; Downes KJ; Cohen-Wolkowiez M
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):199-218. PubMed ID: 32323049
[TBL] [Abstract][Full Text] [Related]
15. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
Ling J; Qian LX; Ding JJ; Jiao Z
Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
[TBL] [Abstract][Full Text] [Related]
16. External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab.
Konecki C; Feliu C; Cazaubon Y; Giusti D; Tonye-Libyh M; Brixi H; Cadiot G; Biron A; Djerada Z
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452152
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of type I error rates when modeling ordered categorical data in NONMEM.
Wählby U; Matolcsi K; Karlsson MO; Jonsson EN
J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):61-74. PubMed ID: 15346852
[TBL] [Abstract][Full Text] [Related]
18. Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT.
Bulitta JB; Bingölbali A; Shin BS; Landersdorfer CB
AAPS J; 2011 Jun; 13(2):201-11. PubMed ID: 21369876
[TBL] [Abstract][Full Text] [Related]
19. A fast method for testing covariates in population PK/PD Models.
Khandelwal A; Harling K; Jonsson EN; Hooker AC; Karlsson MO
AAPS J; 2011 Sep; 13(3):464-72. PubMed ID: 21725709
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions.
Lavielle M; Ribba B
Pharm Res; 2016 Dec; 33(12):2979-2988. PubMed ID: 27604892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
